We are excited to share that we have fulfilled all regulatory closing conditions for our pending transaction with Novo Holdings. We now expect to close the transaction in the coming days. In our next chapter under private ownership, Catalent will be well-positioned to drive innovation and enhance offerings for the benefit of customers and the patients they serve, ultimately accelerating our strategy to create value for stakeholders. We continue to provide unparalleled service to our customers, guided by our mission and Patient First culture. Learn more here: https://ow.ly/vY5b50Ur6Mf https://bit.ly/3VJlnsh
Global Marketing Manager-Catalent Pharma Solutions
1dCongrats Graciela!